copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Leadership - Novavax President and Chief Executive Officer Meet our leadership team, focused on building partnership with industry, government and other organizations to help solve health challenges
Two Years Into Novavax Reset, CEO Jacobs Hunts for Silver Linings After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs says the company is at a pivot point In February 2023, Novavax warned investors that it might not be able to continue operations for another year
Novavax - Wikipedia Novavax, Inc , based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases The company's first and only commercial product is the Novavax COVID-19 vaccine
Novavax CEO and Key Executive Team - Craft. co Novavax's Director, President and Chief Executive Officer is Stanley C Erck Other executives include Frank Czworka, Senior Vice President, Global Sales, Trade Distribution; Rick Crowley, Executive Vice President, Chief Operations Officer and 27 others See the full leadership team at Craft
Novavax Management - Simply Wall St Mr John Charles Jacobs, M B A , serves as Chief Executive Officer and Director of Novavax, Inc since January 23, 2023 and serves as its President from January 23, 2023
Novavax Names John C. Jacobs as New President CEO - LinkedIn Novavax Names John C Jacobs as New President CEO * Current President CEO Stan Erck to retire * Novavax is well-positioned to execute on its strategy, with global authorizations for its
Novavax names new CEO | Pharma Manufacturing Novavax's president and CEO, Stanley Erck, will head off to retirement later this month, and the Maryland-based vaccine specialist has officially named his replacement
Novavax Names John C. Jacobs as New President Chief Executive Officer . . . GAITHERSBURG, Md , Jan 9, 2023 PRNewswire — Novavax, Inc (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that John C Jacobs will succeed Stanley C Erck as President and Chief Executive Officer and a member of the Board of Directors
John C. Jacobs | Novavax John C Jacobs joined Novavax as president and chief executive officer, and a member of the board of directors, in January 2023 He is a seasoned industry leader who has more than 25 years of commercial, operations, business and leadership experience across multiple therapeutic areas